Clinical Trial Update: Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial assessing oral Trigonella foenum-graecum seed extract versus placebo for non-alcoholic fatty liver disease has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Trigonella foenum-graecum seed extract

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2, Phase 3 | Status: COMPLETED